Paper39299010
Effects of xylazine on naloxone-precipitated fentanyl withdrawal in male and female rats.
Carlson HN and 2 others. Drug Alcohol Depend, 2024. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Effects of xylazine on naloxone-precipitated fentanyl withdrawal in male and female rats. Papers, record 39299010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39299010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of xylazine on naloxone-precipitated fentanyl withdrawal in male and female rats.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Substance Withdrawal Syndrome | Major topic |
| Naloxone | Major topic |
| Fentanyl | Major topic |
| Xylazine | Major topic |
| Rats, Long-Evans | Major topic |
| Narcotic Antagonists | Major topic |
| Animals | |
| Male | |
| Rats | |
| Female | |
| Analgesics, Opioid | |
| Behavior, Animal |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DA031725 | NIDA NIH HHS | United States | R01DA031725 | PubMed and NIH | NIH RePORTER |
| R01 DA045364 | NIDA NIH HHS | United States | R01DA045364 | PubMed and NIH | NIH RePORTER |
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37470999 | Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats. | Exp Clin Psychopharmacol | 2024 | https://conductscience.org/library/papers/37470999 | PubMed |
| 2 | 16289800 | Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats. | Pain | 2005 | https://conductscience.org/library/papers/16289800 | PubMed |
| 3 | 21068718 | The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats. | Neuropsychopharmacology | 2011 | https://conductscience.org/library/papers/21068718 | PubMed |
| 4 | 39121896 | 3,3-Dibromoflavanone, a synthetic flavonoid derivative for pain management with antidepressant-like effects and fewer side effects than those of morphine in mice. | Chem Biol Interact | 2024 | https://conductscience.org/library/papers/39121896 | PubMed |
| 5 | 33316293 | Divergent profiles of fentanyl withdrawal and associated pain in mice and rats. | Pharmacol Biochem Behav | 2021 | https://conductscience.org/library/papers/33316293 | PubMed |
| 6 | 8848527 | Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score". | Psychopharmacology (Berl) | 1995 | https://conductscience.org/library/papers/8848527 | PubMed |
| 7 | 31042569 | Sex differences in the expression of morphine withdrawal symptoms and associated activity in the tail of the ventral tegmental area. | Neurosci Lett | 2019 | https://conductscience.org/library/papers/31042569 | PubMed |
| 8 | 38128606 | Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine. | Neuropharmacology | 2024 | https://conductscience.org/library/papers/38128606 | PubMed |
| 9 | 35850178 | Modulation of morphine physical dependence and discriminative stimulus effects by ovarian hormones: Role of estradiol. | Pharmacol Biochem Behav | 2022 | https://conductscience.org/library/papers/35850178 | PubMed |
| 10 | 37003572 | Advances in the characterization of negative affect caused by acute and protracted opioid withdrawal using animal models. | Neuropharmacology | 2023 | https://conductscience.org/library/papers/37003572 | PubMed |
| 11 | 18308382 | Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze. | Pharmacol Biochem Behav | 2008 | https://conductscience.org/library/papers/18308382 | PubMed |
| 12 | 9678657 | Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. | Pharmacol Biochem Behav | 1998 | https://conductscience.org/library/papers/9678657 | PubMed |
| 13 | 30701615 | Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. | Am J Addict | 2019 | https://conductscience.org/library/papers/30701615 | PubMed |
| 14 | 23467277 | Noradrenergic synaptic function in the bed nucleus of the stria terminalis varies in animal models of anxiety and addiction. | Neuropsychopharmacology | 2013 | https://conductscience.org/library/papers/23467277 | PubMed |
| 15 | 566320 | Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. | J Pharmacol Exp Ther | 1978 | https://conductscience.org/library/papers/566320 | PubMed |
| 16 | 37384558 | Illicitly Manufactured Fentanyl-Involved Overdose Deaths with Detected Xylazine - United States, January 2019-June 2022. | MMWR Morb Mortal Wkly Rep | 2023 | https://conductscience.org/library/papers/37384558 | PubMed |
| 17 | 36704210 | Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: A case series. | J Am Coll Emerg Physicians Open | 2023 | https://conductscience.org/library/papers/36704210 | PubMed |
| 18 | 17610870 | The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal. | Eur J Pharmacol | 2007 | https://conductscience.org/library/papers/17610870 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42600850 | Xylazine, veterinary anesthetic and recreational drug adulterant, reduces cephalic regeneration and alters defensive responding in planarians. | Neurotoxicology | 2026 | https://conductscience.org/library/papers/42600850 | PubMed |
| 42453353 | Discovery, Structural Characterization, and Preclinical Evaluation of Monoclonal Antibodies against Xylazine Poisoning. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/42453353 | PubMed |
| 42192162 | Adverse maternal and neonatal effects associated with perinatal xylazine exposure: a systematic review. | J Perinatol | 2026 | https://conductscience.org/library/papers/42192162 | PubMed |
| 41668254 | Xylazine Exposure and Association With Early Physiological and Withdrawal Symptoms in People With Opioid Use Disorder. | J Addict Med | 2026 | https://conductscience.org/library/papers/41668254 | PubMed |
| 41301461 | Within- and Between-Subject Analyses of the Effects of Chronic Xylazine on Negative Phototaxis in Two Planarian Species. | Biomolecules | 2025 | https://conductscience.org/library/papers/41301461 | PubMed |
| 41054596 | Naloxone reversal of the cardiorespiratory depressant effects of opioids and mixtures of opioids and stimulants in rats. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41054596 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39299010
GET https://conductscience.org/api/papers/v1/39299010/authors